Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research
|
February 12, 2019
Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial
Benjamin Lacas, Olivier Bouché, Pierre-Luc Etienne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 13, 2023
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses
Elaine Limkin, Pierre Blanchard, Benjamin Lacas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2017
Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
Frances A Shepherd, Benjamin Lacas, Gwénaël Le Teuff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 23, 2016
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis
Xiaoli Ma, Gwénaël Le Teuff, Benjamin Lacas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 7, 2021
Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
The Lancet. Oncology
|
March 22, 2015
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial
Patricia Pautier, Anne Floquet, Christine Chevreau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2022
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA
Jordi Remon, Benjamin Lacas, Roy Herbst, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 8, 2022
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 15, 2021
Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Clinical Lung Cancer
|
November 12, 2018
LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer
Lesley Seymour, Gwénaël Le Teuff, Elisabeth Brambilla, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Expert Review of Pharmacoeconomics & Outcomes Research
|
February 12, 2019
Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial
Benjamin Lacas, Olivier Bouché, Pierre-Luc Etienne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 13, 2023
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses
Elaine Limkin, Pierre Blanchard, Benjamin Lacas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2017
Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
Frances A Shepherd, Benjamin Lacas, Gwénaël Le Teuff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 23, 2016
Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis
Xiaoli Ma, Gwénaël Le Teuff, Benjamin Lacas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 7, 2021
Association of different fractionation schedules for prophylactic cranial irradiation with toxicity and brain metastases-free survival in stage III non-small cell lung cancer: A pooled analysis of individual patient data from three randomized trials
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
The Lancet. Oncology
|
March 22, 2015
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial
Patricia Pautier, Anne Floquet, Christine Chevreau, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 14, 2022
ANtiangiogenic Second-line Lung cancer Meta-Analysis on individual patient data in non-small cell lung cancer: ANSELMA
Jordi Remon, Benjamin Lacas, Roy Herbst, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 8, 2022
Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 15, 2021
Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer
Willem J A Witlox, Bram L T Ramaekers, Benjamin Lacas, et al.
Clinical Lung Cancer
|
November 12, 2018
LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer
Lesley Seymour, Gwénaël Le Teuff, Elisabeth Brambilla, et al.
Page
of 3